When insurance requests clinical justification for GLP-1 therapy, genetic insights strengthen prior authorization applications by demonstrating biological predisposition to treatment benefit
Strategies to manage them include starting with a low dose and gradually increasing, eating smaller, more frequent meals, avoiding fatty foods, and staying well-hydrated
While immunological targets such as TNF-, IL-17, and IL-23 are well-established in PsO pathogenesis, a deeper understanding of their therapeutic relevance is essential
GLP-1 prescriptions may vary based on your insurance coverage
* Percent Daily Values are Based on a 2,000 Calorie Diet
While Wegovy uses semaglutide for weight loss, other formulations help treat diabetes and prevent heart attacks, and even help manage serious liver disease